RIVM welcomes German Federal Centre for Health Education Today RIVM’s Centre for Healthy Living (CGL) welcomes the Bundeszentrale für gesundheitliche Aufklärung.
Scientific background information on rubber granulate now available in English In December 2016, RIVM published in Dutch the results of its research into the health risks of playing sports on synthetic turf pitches with rubber granulate.
Environmentally harmful pharmaceuticals cannot be replaced yet RIVM investigates how the impact of pharmaceutical residues on the environment may be reduced.
Off-label use of medicinal products in the European Union Off-label use of medicinal products in the European Union is common, both in primary and in secondary care.
Learn how students can contribute to research from NASA, KNMI, RIVM and WUR The Global Learning and Observation to Benefit the Environment (GLOBE) program in the Netherlands (GLOBE Netherlands) is organising the annual GLOBE day on 21 March .
Age and vaccination history affect immune responses after natural infection with whooping cough Age plays a role in immune responses after a natural infection with Bordetella pertussis, the bacterium that causes the contagious respiratory infection pertussis (whooping cough).
Benefits and bottlenecks for early marketing authorisation of new medicines Patients are asking increasingly often for quicker access to new, innovative medicines. This requires a more effective use of flexible marketing authorisation procedures.
European Baseline Report SUSTAIN The SUSTAIN project has published the European baseline report titled ‘Integrated care for older people living at home – Current situation and ambition of sites participating in the SUSTAIN project
Particle contamination on Silimed breast implants poses minimal risk Particles were found on Silimed silicone-based breast implants that should not be there. These included man-made mineral fibres, such as glasswool and rockwool.
EFSA agrees with RIVM that potential effect of BPA on the immune system requires further attention RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.